Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 2, 2015, Pages 491-499

  Nassiri, Maria ^a   Babina, Magda ^a   Dölle, Sabine ^a   Edenharter, Günter ^b   Ruëff, Franziska ^c   Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Edenharter Research   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anaphylaxis; angiotensin converting enzyme inhibitor; cardiovascular medication; cofactor; mast cells; blocker

Indexed keywords

BRADYKININ; CHYMASE; HISTAMINE; LEUKOTRIENE C4; METOPROLOL; PROSTAGLANDIN D2; RAMIPRIL; SEROTONIN; ANTIHYPERTENSIVE AGENT; AUTACOID; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN E;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BONE MARROW DERIVED MAST CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; FEMALE; HISTAMINE RELEASE; HUMAN; IN VIVO STUDY; MALE; MAST CELL; MEDIATOR; MEDIATOR RELEASE; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PASSIVE SYSTEMIC ANAPHYLAXIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC ANAPHYLAXIS; TREATMENT DURATION; ADULT; ANIMAL; CHILD; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; REGISTER; RISK; SEVERITY OF ILLNESS INDEX;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; ANAPHYLAXIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; MALE; MAST CELLS; METOPROLOL; MICE; RAMIPRIL; REGISTRIES; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84922379378     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.09.004     Document Type: Article

References (49)

1. S.F. Kemp, and R.F. Lockey Anaphylaxis: a review of causes and mechanisms J Allergy Clin Immunol 110 2002 341 348
2. M. Triggiani, V. Patella, R.I. Staiano, F. Granata, and G. Marone Allergy and the cardiovascular system Clin Exp Immunol 153 suppl 1 2008 7 11
3. M. Worm, G. Edenharter, F. Rueff, K. Scherer, C. Pfohler, and V. Mahler Symptom profile and risk factors of anaphylaxis in Central Europe Allergy 67 2012 691 698
4. M. Ben-Shoshan, and A.E. Clarke Anaphylaxis: past, present and future Allergy 66 2011 1 14
5. K. Beyer, O. Eckermann, S. Hompes, L. Grabenhenrich, and M. Worm Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions Allergy 67 2012 1451 1456
6. A. Helbling, T. Hurni, U.R. Mueller, and W.J. Pichler Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern Clin Exp Allergy 34 2004 285 290
7. K. Brockow, C. Jofer, H. Behrendt, and J. Ring Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients Allergy 63 2008 226 232
8. M. Worm, M. Babina, and S. Hompes Causes and risk factors for anaphylaxis J Dtsch Dermatol Ges 11 2013 44 50
9. S. Hompes, A. Kohli, K. Nemat, K. Scherer, L. Lange, and F. Rueff Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries Pediatr Allergy Immunol 22 2011 568 574
10. F. Wolbing, J. Fischer, M. Koberle, S. Kaesler, and T. Biedermann About the role and underlying mechanisms of cofactors in anaphylaxis Allergy 68 2013 1085 1092
11. B.Y. Thong, and C. Yeow Anaphylaxis during surgical and interventional procedures Ann Allergy Asthma Immunol 92 2004 619 628
12. N. Grosman Histamine release from isolated rat mast cells: effect of morphine and related drugs and their interaction with compound 48/80 Agents Actions 11 1981 196 203
13. C.H. Sheen, R.P. Schleimer, and M. Kulka Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation Allergy 62 2007 532 538
14. J. Trcka, C. Schmidt, C.S. Seitz, E.B. Brocker, G.E. Gross, and A. Trautmann Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol 190 2008 666 670
15. L.M. Webb, and P. Lieberman Anaphylaxis: a review of 601 cases Ann Allergy Asthma Immunol 97 2006 39 43
16. U.R. Mueller Cardiovascular disease and anaphylaxis Curr Opin Allergy Clin Immunol 7 2007 337 341
17. J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A.P. Maggioni, and H. Dargie Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology Eur Heart J 25 2004 1454 1470
18. L.M. Poulos Trends in hospitalization for anaphylaxis, angioedema, and urticaria in Australia, 1193-1994 to 2004-2005 Am Acad Allergy Asthma Immunol 120 2007 878 884
19. D. Siegel, and J. Lopez Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure JAMA 278 1997 1745 1748
20. F. Rueff, B. Przybilla, M.B. Bilo, U. Muller, F. Scheipl, and W. Aberer Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase - a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity J Allergy Clin Immunol 124 2009 1047 1054
21. J. Stoevesandt, J. Hain, A. Kerstan, and A. Trautmann Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema J Allergy Clin Immunol 130 2012 698 704.e1
22. J.M. Renaudin, E. Beaudouin, C. Ponvert, P. Demoly, and D.A. Moneret-Vautrin Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010 Allergy 68 2013 929 937
23. S.G. Brown, S.F. Stone, D.M. Fatovich, S.A. Burrows, A. Holdgate, and A. Celenza Anaphylaxis: clinical patterns, mediator release, and severity J Allergy Clin Immunol 132 2013 1141 1149.e5
24. T.J. Ryan, J.L. Anderson, E.M. Antman, B.A. Braniff, N.H. Brooks, and R.M. Califf ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 94 1996 2341 2350
25. H. Liu, X. Xing, L. Huang, Z. Huang, and H. Yuan The expression level of myocardial beta1-adrenergic receptor affects metoprolol antihypertensive effects: a novel mechanism for interindividual difference Med Hypotheses 81 2013 71 72
26. P. Dayer, T. Leemann, A. Marmy, and J. Rosenthaler Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol Eur J Clin Pharmacol 28 1985 149 153
27. M. Grafe, C. Bossaller, K. Graf, W. Auch-Schwelk, C.R. Baumgarten, and A. Hildebrandt Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells Am J Physiol Heart Circ Physiol 264 1993 H1493 H1497
28. A.A. Ahimastos, A.K. Natoli, A. Lawler, P.A. Blombery, and B.A. Kingwell Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture Hypertension 45 2005 1194 1199
29. R.P. Siraganian Automated histamine release. A method for in vitro diagnosis Int Arch Allergy Appl Immunol 49 1975 108 110
30. S. Guhl, R. Stefaniak, M. Strathmann, M. Babina, H. Piazena, and B.M. Henz Bivalent effect of UV light on human skin mast cells-low-level mediator release at baseline but potent suppression upon mast cell triggering J Invest Dermatol 124 2005 453 456
31. J. Ring, and K. Messmer Incidence and severity of anaphylactoid reactions to colloid volume substitutes Lancet 1 1977 466 469
32. I. Miyajima, D. Dombrowicz, T.R. Martin, J.V. Ravetch, J.P. Kinet, and S.J. Galli Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis J Clin Invest 99 1997 901 914
33. D.D. Metcalfe, R.D. Peavy, and A.M. Gilfillan Mechanisms of mast cell signaling in anaphylaxis J Allergy Clin Immunol 124 2009 639 648
34. E. Ono, M. Taniguchi, H. Mita, Y. Fukutomi, N. Higashi, and E. Miyazaki Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis Clin Exp Allergy 39 2009 72 80
35. R.L. Stevens, D.S. Friend, H.P. McNeil, V. Schiller, N. Ghildyal, and K.F. Austen Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases Proc Natl Acad Sci U S A 91 1994 128 132
36. P.A. Knight, S.H. Wright, C.E. Lawrence, Y.Y. Paterson, and H.R. Miller Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1 J Exp Med 192 2000 1849 1856
37. R.P. Schleimer, E.S. Schulman, D.W. MacGlashan Jr., S.P. Peters, E.C. Hayes, and G.K. Adams 3rd Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells J Clin Invest 71 1983 1830 1835
38. D.W. MacGlashan Jr., R.P. Schleimer, S.P. Peters, E.S. Schulman, G.K. Adams 3rd, and H.H. Newball Generation of leukotrienes by purified human lung mast cells J Clin Invest 70 1982 747 751
39. R.P. Schleimer, D.W. MacGlashan Jr., S.P. Peters, R.N. Pinckard, N.F. Adkinson Jr., and L.M. Lichtenstein Characterization of inflammatory mediator release from purified human lung mast cells Am Rev Respir Dis 133 1986 614 617
40. M.C. Weston, and P.T. Peachell Regulation of human mast cell and basophil function by cAMP Gen Pharmacol 31 1998 715 719
41. R.P. Xiao Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins Sci STKE 104 2001 re15
42. P. Peachell Regulation of mast cells by beta-agonists Clin Rev Allergy Immunol 31 2006 131 142
43. M.R. Bristow Beta-adrenergic receptor blockade in chronic heart failure Circulation 101 2000 558 569
44. J.R. White, D.H. Pluznik, K. Ishizaka, and T. Ishizaka Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells Proc Natl Acad Sci U S A 82 1985 8193 8197
45. T. Kato Role of protein kinase A in the inhibition of human mast cell histamine release by β-adrenergic receptor agonists Allergol Int 53 2002 197 203
46. M. Kimata, M. Shichijo, T. Miura, I. Serizawa, N. Inagaki, and H. Nagai Ca2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells Biochem Biophys Res Commun 257 1999 895 900
47. E. Razin Signal transduction in mast cells and basophils 1999 Springer-Verlag New York
48. N. Chakravarty, and W.J. Yu Role of intracellular calcium in histamine release from rat mast cells Agents Actions 14 1984 386 391
49. F.L. Pearce, M. Ennis, A. Truneh, and J.R. White Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells Agents Actions 11 1981 51 54